These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838 [TBL] [Abstract][Full Text] [Related]
3. Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Heinemann LA; Assmann A; DoMinh T; Garbe E Eur J Contracept Reprod Health Care; 1999 Jun; 4(2):67-73. PubMed ID: 10427481 [TBL] [Abstract][Full Text] [Related]
6. Relevance of biological properties of progestogen of oral contraceptives in treatment of androgen excess symptoms. Pang S J Clin Endocrinol Metab; 1990 Jul; 71(1):5-7. PubMed ID: 2370300 [No Abstract] [Full Text] [Related]
7. Importance of the type of the progestogen in oral contraceptives. Eisalo A; Luukkainen T; Järvinen PA Acta Obstet Gynecol Scand; 1966; 45(S9):47-51. PubMed ID: 5958398 [No Abstract] [Full Text] [Related]
8. Experience with sequential and low-dose-progestogen oral contraceptives. Jackson MC Lancet; 1969 Sep; 2(7619):540-1. PubMed ID: 4184854 [No Abstract] [Full Text] [Related]
9. Cortisol metabolism after oral contraceptives: total plasma cortisol and the free cortisol index. Brien TG Br J Obstet Gynaecol; 1975 Dec; 82(12):987-91. PubMed ID: 1203215 [TBL] [Abstract][Full Text] [Related]
10. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data. Mann JI Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056 [TBL] [Abstract][Full Text] [Related]
11. Low-dosage oral progestogen. Black WP Br Med J; 1968 Jun; 2(5604):562. PubMed ID: 5724468 [No Abstract] [Full Text] [Related]
12. A review of the use of progestogen-only minipills for contraception during lactation. Fraser IS Reprod Fertil Dev; 1991; 3(3):245-54. PubMed ID: 1947224 [TBL] [Abstract][Full Text] [Related]
13. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2. Visser J; Snel M; Van Vliet HA Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD003990. PubMed ID: 23543528 [TBL] [Abstract][Full Text] [Related]
14. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2. Visser J; Snel M; Van Vliet HA Cochrane Database Syst Rev; 2006 Oct; (4):CD003990. PubMed ID: 17054193 [TBL] [Abstract][Full Text] [Related]
15. Effect of oral contraceptive progestins on serum copper concentration. Berg G; Kohlmeier L; Brenner H Eur J Clin Nutr; 1998 Oct; 52(10):711-5. PubMed ID: 9805216 [TBL] [Abstract][Full Text] [Related]
16. SYMPOSIUM ON PROGESTOGEN-ESTROGEN COMPOUNDS. ROCK J Appl Ther; 1964 May; 6():406-9. PubMed ID: 14144490 [No Abstract] [Full Text] [Related]
17. Effects of an oral progestogen of feedlot heifers. Young AW; Cundiff LV; Bradley NW J Anim Sci; 1969 Feb; 28(2):224-6. PubMed ID: 5813035 [No Abstract] [Full Text] [Related]
18. Drospirenone: a novel progestogen used as an oral contraceptive without an estrogen component. Paton DM Drugs Today (Barc); 2020 May; 56(5):321-328. PubMed ID: 32406879 [TBL] [Abstract][Full Text] [Related]
19. Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa). Shapiro S; Rosenberg L; Hoffman M; Kelly JP; Cooper DD; Carrara H; Denny LE; du Toit G; Allan BR; Stander IA; Williamson AL Cancer Causes Control; 2003 Jun; 14(5):485-95. PubMed ID: 12946044 [TBL] [Abstract][Full Text] [Related]